2008-07-04 19:29:17 - www.companiesandmarkets.com adds new report - GlaxoSmithKline plc - PharmaVitae Profile

www.companiesandmarkets.com/Summary-Market-Report/GlaxoSmithKlin ..
Introduction

This analysis examines the historical and forecast performance for GSK in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Scope

Highlights

Reasons to Purchase

Benchmark GlaxoSmithKline´s performance against

key rivals in the ethical pharmaceutical sector Analyze the factors that will underscore a forecast ethical pharmaceutical sales CAGR of -2.1% for GlaxoSmithKline over 2006-12 Assess the generic threat faced by GlaxoSmithKline over the period 2006-12 and how this compares to generic risk across the Big Pharma peer set